← FDA Drug Approvals (Drugs@FDA)

NATEGLINIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CADILA PHARMS LTD · Approved 2019-04-19

Drug application

FDA Application #

ANDA206432

Application type

Abbreviated New Drug Application (Generic)

Brand name

NATEGLINIDE

Generic name

NATEGLINIDE

Active ingredients

NATEGLINIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CADILA PHARMS LTD

Manufacturer

Modavar Pharmaceuticals LLC

First approval

2019-04-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown